InvestorsHub Logo

BioHunter

07/25/16 10:46 AM

#94589 RE: bigcat2 #94588

$XXII they were going to run out in October. This easily gets them through key FDA decision in Q4. Strong raise on excellent terms all things considered. They needed cash bad. IMO it was already priced into the stock at .80. Looks like I had that right.